Mezzion Pharma Co.Ltd (140410) — Net Asset Quality Index
Mezzion Pharma Co.Ltd (140410) has a Net Asset Quality Index of 17.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩98.02 Billion minus total liabilities of ₩80.83 Billion yields net assets of ₩17.19 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of Mezzion Pharma Co.Ltd to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Mezzion Pharma Co.Ltd Net Asset Quality Index Over Time (2012–2025)
This chart shows how Mezzion Pharma Co.Ltd's Net Asset Quality Index has evolved across 12 annual periods from 2012 to 2025. As of December 2025, the index stands at 17.5%, representing net assets of ₩17.19 Billion against total assets of ₩98.02 Billion KRW. See working capital position of Mezzion Pharma Co.Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Mezzion Pharma Co.Ltd (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Mezzion Pharma Co.Ltd from 2012 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 140410 stock market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 17.5% | ₩17.19 Billion | ₩98.02 Billion | ₩80.83 Billion | ▼ -44.7 pp |
| 2024 | 62.2% | ₩46.06 Billion | ₩74.00 Billion | ₩27.94 Billion | ▼ -4.4 pp |
| 2023 | 66.7% | ₩61.44 Billion | ₩92.15 Billion | ₩30.70 Billion | ▲ +18.1 pp |
| 2022 | 48.6% | ₩26.24 Billion | ₩54.02 Billion | ₩27.78 Billion | ▼ -26.2 pp |
| 2021 | 74.8% | ₩62.79 Billion | ₩83.93 Billion | ₩21.14 Billion | ▼ -0.3 pp |
| 2020 | 75.1% | ₩56.81 Billion | ₩75.63 Billion | ₩18.82 Billion | ▲ +2.4 pp |
| 2019 | 72.7% | ₩42.83 Billion | ₩58.87 Billion | ₩16.04 Billion | ▼ -3.6 pp |
| 2018 | 76.4% | ₩57.32 Billion | ₩75.06 Billion | ₩17.74 Billion | ▲ +4.6 pp |
| 2017 | 71.8% | ₩53.17 Billion | ₩74.04 Billion | ₩20.87 Billion | ▲ +16.7 pp |
| 2016 | 55.1% | ₩52.81 Billion | ₩95.90 Billion | ₩43.09 Billion | ▼ -5.6 pp |
| 2015 | 60.7% | ₩62.54 Billion | ₩103.05 Billion | ₩40.52 Billion | ▼ -33.4 pp |
| 2012 | 94.1% | ₩63.34 Billion | ₩67.30 Billion | ₩3.97 Billion | — |